当前位置:首页 - 行情中心 - 万孚生物(300482) - 财务分析 - 现金流量表

万孚生物

(300482)

  

流通市值:71.60亿  总市值:78.09亿
流通股本:4.29亿   总股本:4.68亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,180,359,235.7586,603,192.812,455,407,503.831,752,258,544.33
  客户存款和同业存放款项净增加额---0
  向中央银行借款净增加额---0
  向其他金融机构拆入资金净增加额---0
  收到原保险合同保费取得的现金---0
  收到再保险业务现金净额---0
  保户储金及投资款净增加额---0
  收取利息、手续费及佣金的现金---0
  拆入资金净增加额---0
  回购业务资金净增加额---0
  收到的税费返还32,490,311.924,716,434.5819,366,624.9511,320,256.15
  收到其他与经营活动有关的现金32,686,230.5710,953,390.8436,360,754.1626,759,545.35
  经营活动现金流入的其他项目---0
  经营活动现金流入小计1,245,535,778.19602,273,018.232,511,134,882.941,790,338,345.83
  购买商品、接受劳务支付的现金261,361,551.8491,655,442.57617,224,111.5535,744,810.8
  客户贷款及垫款净增加额---0
  存放中央银行和同业款项净增加额---0
  支付原保险合同赔付款项的现金---0
  支付利息、手续费及佣金的现金---0
  支付保单红利的现金---0
  支付给职工以及为职工支付的现金318,238,363.17173,172,391.59847,739,686.38687,094,266.64
  支付的各项税费38,868,906.4711,121,672.76124,949,520.95117,553,373
  支付其他与经营活动有关的现金203,068,593.59108,153,783.25458,184,003.26397,236,699.67
  经营活动现金流出的其他项目---0
  经营活动现金流出小计821,537,415.07384,103,290.172,048,097,322.091,737,629,150.11
  经营活动产生的现金流量净额423,998,363.12218,169,728.06463,037,560.8552,709,195.72
二、投资活动产生的现金流量:
  收回投资收到的现金2,795,339,990.121,588,523,888.784,611,416,456.033,577,903,506.11
  取得投资收益收到的现金31,169,132.5818,912,385.0848,704,644.7735,447,154.71
  处置固定资产、无形资产和其他长期资产收回的现金净额36,408.9824,948.98453,801.0631,083.11
  处置子公司及其他营业单位收到的现金净额807,660-1,009,227.872,857,406.59
  收到的其他与投资活动有关的现金---0
  投资活动现金流入小计2,827,353,191.681,607,461,222.844,661,584,129.733,616,239,150.52
  购建固定资产、无形资产和其他长期资产支付的现金77,533,463.2836,358,438.76304,552,406.53205,887,567.42
  投资支付的现金3,228,859,9901,879,838,081.424,774,491,696.473,702,393,071.47
  质押贷款净增加额---0
  取得子公司及其他营业单位支付的现金---0
  支付其他与投资活动有关的现金---0
  投资活动现金流出小计3,306,393,453.281,916,196,520.185,079,044,1033,908,280,638.89
  投资活动产生的现金流量净额-479,040,261.6-308,735,297.34-417,459,973.27-292,041,488.37
三、筹资活动产生的现金流量:
  吸收投资收到的现金---0
  其中:子公司吸收少数股东投资收到的现金---0
  取得借款收到的现金---0
  收到其他与筹资活动有关的现金1,374,277.71653,096.587,046,953.464,736,302.25
  筹资活动现金流入小计1,374,277.71653,096.587,046,953.464,736,302.25
  偿还债务支付的现金---0
  分配股利、利润或偿付利息支付的现金102,664,544.18-200,577,371.67205,920,844.32
  其中:子公司支付给少数股东的股利、利润--2,940,0002,592,000
  支付其他与筹资活动有关的现金00216,812,245.46184,874,983.27
  筹资活动现金流出小计102,664,544.180417,389,617.13390,795,827.59
  筹资活动产生的现金流量净额-101,290,266.47653,096.58-410,342,663.67-386,059,525.34
四、汇率变动对现金及现金等价物的影响-3,606,874.27-1,385,935.36-1,339,102.5-266,391.73
五、现金及现金等价物净增加额-159,939,039.22-91,298,408.06-366,104,178.59-625,658,209.72
  加:期初现金及现金等价物余额461,998,850.06461,998,850.06828,103,028.65828,103,028.65
  期末现金及现金等价物余额302,059,810.84370,700,442461,998,850.06202,444,818.93
补充资料:
  净利润125,155,264.06--69,658,473.46-
  资产减值准备4,060,710.91-24,661,464.55-
  固定资产和投资性房地产折旧108,359,185.18-222,596,633.58-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧108,359,185.18-222,596,633.58-
  无形资产摊销18,026,558.07-35,362,085.74-
  长期待摊费用摊销1,818,637.75-5,029,881.04-
  处置固定资产、无形资产和其他长期资产的损失0--318,789.99-
  固定资产报废损失3,000,374.38-4,988,270.15-
  公允价值变动损失-13,030,142.94--13,639,950.87-
  财务费用15,454,593.48-25,640,854.92-
  投资损失-7,683,449.31--39,786,048.52-
  递延所得税15,739,292.81--50,760,886.55-
  其中:递延所得税资产减少21,806,608.45--36,544,624.42-
    递延所得税负债增加-6,067,315.64--14,216,262.13-
  存货的减少-42,841,356.08-70,340,155.59-
  经营性应收项目的减少78,730,148.97-271,583,502.28-
  经营性应付项目的增加115,606,771.37--134,926,097.1-
  其他0-106,418,000-
  融资租入固定资产--1,304,714.59-
  现金的期末余额302,059,810.84-461,998,850.06-
  减:现金的期初余额461,998,850.06-828,103,028.65-
  现金及现金等价物的净增加额-159,939,039.22--366,104,178.59-
公告日期2026-08-242026-04-232026-04-232025-10-27
审计意见(境内)标准无保留意见
TOP↑